Article info
PDFCase Reports: Rare disease
Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine
- Correspondence to Dr Masatoshi Inoue; inoue.masatoshi333{at}gmail.com
Citation
Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine
Publication history
- Accepted March 8, 2022
- First published March 15, 2022.
Online issue publication
January 24, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.